Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2003
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186319 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186317 Identifying modulators of calcium-binding protein (CIB)/mixed lineage kinase 2 (MLK2) complexes for treatment and prevention of nervous system disorders
10/02/2003US20030186307 Propagating and replicating procine circoviruses (PCV) for use in vaccine development and as diagnostic aides detecting viral infection in swine; animal husbandry
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186282 Using purified telomerase to identify telomerase activators and inhibitors
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186271 Pharmaceutical compositions in particulate form
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186244 Using stored nucleotide sequence information to screen genome databases to detect restriction fragment length polymorphisms which are associated with genetic disorders
10/02/2003US20030186236 Diagnosis and prevention of infectibity of swine with porcine reproductive and respiratory syndrome virus; viricides; animal husbandry
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186224 CD4+ T-lymphocyte-specific hepatitis C virus-epitopes
10/02/2003US20030186219 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
10/02/2003US20030185892 Intraocular delivery compositions and methods
10/02/2003US20030185859 Lyme disease vaccine
10/02/2003US20030185858 Engineered for both enhanced stability of self-assembled particles and the display of an immunogenic epitope.
10/02/2003US20030185856 Immunizing young hens with antigen proteins of E. coli
10/02/2003US20030185855 Which has lost its transducing properties as a result of a DNA sequence change in the gene coding for Vmw65 protein; expressable heterologous gene inserted; under the control of the immediate early 1 gene enhancer of cytomegalovirus
10/02/2003US20030185854 Use of recombinant hepatitis B core particles to develop vaccines against infectious pathogens and malignancies
10/02/2003US20030185852 Parasitic protozoan isolate
10/02/2003US20030185851 Tet transactivator system
10/02/2003US20030185850 Protective peptides neurotoxin of C. botulinum
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185848 Using such isolated antigens for producing immune responses in bovines or other non-human animals.
10/02/2003US20030185847 Peptide-based immunotherapeutic agent for treating allergic diseases
10/02/2003US20030185846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030185845 Such as variants of interleukin 5 and tumour necrosis factor alpha
10/02/2003US20030185843 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185840 Induction of tumor immunity by variants of folate binding protein
10/02/2003US20030185837 Serodiagnostic assays
10/02/2003US20030185836 Cryptosporidium sporozoite antigens
10/02/2003US20030185835 Antigen; an imidazoquinoline amine, imidazopyridine amine, 6,7-fused cycloalkylimidazopyridine amine, 1,2-bridged imidazoquinoline amine, thiazolo- and oxazolo-quinolinamine or pyrdinamine, or (tetrahydro)imidazonaphthyridine
10/02/2003US20030185833 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185825 Novel immunotoxins and methods of inducing immune tolerance
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185820 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185810 Tumor radiosensitization using gene therapy
10/02/2003US20030185808 Prostate cell lines
10/02/2003US20030185806 Intact cells that express major histocompatibility antigens with a number of common allotypes from a given mammalian species.
10/02/2003US20030185802 DNA construct operably encoding a vascular endothelial growth factor receptor protein.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185796 Methods of therapy for non-hodgkin's lymphoma
10/02/2003US20030185765 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
10/02/2003US20030185761 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/02/2003CA2484049A1 Imidazoquinoline adjuvants for vaccines
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2479879A1 Neisseria mutants, lipooligosaccharides and immunogenic compositions
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479576A1 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003CA2479528A1 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
10/02/2003CA2479306A1 Egfr ligands and methods of use
10/02/2003CA2478855A1 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/02/2003CA2475529A1 Methods for treating chronic obstructive pulmonary disease (copd)
10/01/2003EP1348768A2 Method of treatment, diagnosis or detection of diabetes
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348460A2 Creating an aerosolized formulation of insulin
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1347994A2 Canine and feline tumour-associated antigen 5t4
10/01/2003EP1347993A2 Superficial zone protein and methods of making and using same
10/01/2003EP1347777A2 Immunogenic complex comprising ribosomes
10/01/2003EP1347776A2 Anti-inflammatory use of polycationic compounds
10/01/2003EP1347775A2 Uses for polycationic compounds as vaccine adjuvants
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1051190B1 Vaccine compositions for mucosal administration comprising chitosan and influenza antigen(s)
10/01/2003EP0937105B1 DNA encoding the variable region of an anti-idiotypic antibody
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
10/01/2003CN1446102A Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
10/01/2003CN1446094A Method for obtaining antigenic structures enhancing specific cross reactivity
10/01/2003CN1446053A Food supplement
10/01/2003CN1445242A Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition
10/01/2003CN1445241A Monochain antibody with dual specificities possessing activity for restraining adherence and aggregation of blood platelets
10/01/2003CN1444996A Oral DNA combination for treating chronic infection of hepatitis B virus
10/01/2003CN1444995A Method for filtering out matters possible to restrain and/or activate target biological activity in a iming at phenomena of spatial allosterism of the target
10/01/2003CN1444994A Production method of the immunity eggs
10/01/2003CN1444992A Method and combination for treating tumors based on ERBB-3
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
1 ... 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 ... 1823